Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The lung stent market was valued at USD 157.55 Million in 2025. It is poised to grow at a CAGR of 6.90% during the forecast period of 2026-2035, and reach USD 307.04 Million by 2035. The market growth is driven by the rising global incidence of lung cancer and chronic respiratory disorders, alongside the growing adoption of minimally invasive bronchoscopic procedures.
The Cleveland Clinic reported in April 2026 that its patient-specific 3D-printed airway stents continue expanding access for patients with complex breathing disorders. Designed using CT scans and proprietary visualisation software, the silicone stents demonstrate longer in-vivo durability than standard stents and shorter procedure times. The technology is fuelling demand for customised lung stents in tertiary care and interventional pulmonology centres.
A March 2026 review on PubMed documented novel applications of 3D-printed custom airway stents in patients with extrinsic vascular compression and bronchopleural fistula, beyond conventional tracheal stenosis indications. The cases highlight rising clinical confidence in customised stent design for complex airway pathologies, accelerating adoption of biodegradable and patient-specific lung stents within hospitals globally.
Compound Annual Growth Rate
6.9%
Value in USD Million
2026-2035
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Lung stents, also known as airway or tracheobronchial stents, are hollow tubular devices placed inside the airway to maintain patency in patients with malignant or benign obstruction caused by tumors, strictures, or tracheomalacia. The market was valued at USD 157.55 Million in 2025 and is poised to grow at a CAGR of 6.90%. The growth is supported by the rising global cancer burden, expanding indications for palliative bronchoscopic stenting, and continual innovation in nitinol, silicone, and hybrid stent designs that improve placement and patient comfort.
Rising Global Burden of Lung Cancer to Accelerate Market Growth
The escalating incidence of lung cancer is a primary factor for lung stent adoption, as stenting offers critical palliation in malignant central airway obstruction. According to the American Cancer Society, around 2.5 million new lung cancer cases were diagnosed worldwide in 2022, accounting for one in eight new cancer diagnoses. This rising incidence continues to strengthen the demand for advanced airway management solutions.
Some of the notable trends in the market are increasing adoption of personalized airway stents, advancement in biomaterial-based stent coatings, and rising minimally invasive lung obstruction treatments.
Amnion-Based Covered Stents to Enhance the Precision Airway Obstruction Management and Market Growth
The growing shift toward biomaterial-enhanced lung stents is improving treatment outcomes for malignant airway obstruction by reducing inflammation, migration, and occlusion risks. The rising demand for advanced covered stent systems is supporting innovation in tracheobronchial interventions. For instance, in October 2024, Peytant Solutions received U.S. FDA De Novo authorization for its AMStent® Tracheobronchial Covered Stent System, designed for malignant airway strictures in adult lung cancer patients. This development strengthens device efficacy in palliative care, and the increasing adoption of such advanced stent technologies is expected to enhance lung stent market growth through improved safety and clinical performance.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Product Type
Market Breakup by Material Type
Market Breakup by Device Type
Market Breakup by Age Group
Market Breakup by End User
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Tracheal Stents Segment Expected to Lead the Lung Stent Market Driven by Rising Upper Airway Obstruction Cases
The market is segmented by product type into tracheal stents, bronchial stents, laryngeal stents, and others. Among these, tracheal stents are expected to lead the market due to their critical role in managing upper airway obstruction, which often presents as a life-threatening condition requiring immediate intervention. The rising incidence of tracheal stenosis caused by prolonged intubation, tracheostomy complications, and malignant airway compression is a key growth driver. Increasing adoption of minimally invasive bronchoscopic stenting procedures further supports demand. As a result, tracheal stents are anticipated to maintain dominance, significantly contributing to the overall expansion of the lung stent market during the forecast period.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America is expected to lead the lung stent market due to its high lung cancer incidence, advanced healthcare infrastructure, and strong adoption of minimally invasive bronchoscopic procedures across the region. According to the World Health Organization, lung cancer in the United States remains a major health burden, with over 218,000 new cases reported in 2022 and more than 131,000 deaths in 2023, highlighting a significant regional disease burden that drives demand for airway stenting solutions. This strong clinical need continues to support sustained market growth across North America.
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Boston Scientific Corporation develops airway stenting solutions for the market through its Dynamic™ (Y) Stent. The bifurcated silicone-stainless steel stent is designed to maintain tracheal and bronchial patency in stenosis and fistula cases. It supports minimally invasive pulmonary interventions, strengthening the company’s role in advanced airway management and respiratory care innovation.
Novatech Industries Private Limited is engaged in the market through its DUMON silicone airway stents, including tracheal, bronchial, and bifurcation variants. These stents are widely used for benign and malignant airway stenosis management. The company focuses on durable, biocompatible stent systems, reinforcing its position in interventional pulmonology and long-term airway support solutions.
Micro-Tech (Nanjing) Co., Ltd. participates in the lung stent market through its airway stents, including tracheal, bronchial, and Y-shaped nitinol stents. The company provides endoscopic respiratory solutions supporting diagnosis and treatment of airway obstruction. Its global distribution and integrated R&D capabilities strengthen its role in minimally invasive pulmonary stenting technologies.
Peytant Solutions operates in the lung stent market with its AMStent® Tracheobronchial Covered Stent System. The amnion-based stent platform is designed for malignant airway obstruction caused by cancer. It reduces inflammation, mucus buildup, and migration, improving palliative outcomes. The company contributes advanced biomaterial innovation to next-generation airway stenting therapies.
Other key players in the market are Abbott, Merit Medical Systems, Inc., E. Benson Hood Laboratories, Inc., Cook Group Incorporated, Taewoong Medical Co., Ltd., NovaTech LLC.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
In 2025, the global lung stent market attained a value of nearly USD 157.55 Million.
The market is projected to grow at a CAGR of 6.90% between 2026 and 2035.
The major drivers of the market include the growing incidences of lung cancer and respiratory problems, the development of biodegradable stent, and the increased demand for customised lung stents.
The increasing prevalence of lung cancer and chronic respiratory disorders globally is a major industry trend aiding the market growth.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Tracheobronchial stents and laryngeal stents are the leading types in the industry.
The leading materials in the market are metal stents, silicone stents, and hybrid stents.
Self-expandable and non-expandable stents are the leading products in the industry.
Hospitals and ambulatory surgery centres are the end-use sectors for the industry.
The major players in the industry are Boston Scientific Corporation, Taewoong Medical Co., Ltd., Micro-Tech (Nanjing) Co., Ltd., Bess Medizintechnik Gmbh, E. Benson Hood Laboratories, Inc., Merit Medical Systems, Inc., and Cook Group Incorporated, among others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Material Type |
|
| Breakup by Device Type |
|
| Breakup by Age Group |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.